GeneGo is Awarded NCI Grant for Development of Systems Biology Database and Tools for Nutrition in Cancer
News Oct 01, 2008
GeneGo Inc. has announced that they were awarded with a Phase I SBIR grant from the National Cancer Institute (NCI) for the development of a platform for understanding the influence of nutrients on cancerogenesis and cancer prevention.
GeneGo will collaborate with FDA investigator, Jim Kaput Director of Personalized Nutrition and Medicine, on the project. The new platform will include a comprehensive manually curated database on nutrition, an OMICs data repository, advanced search and statistical modeling tools.
“For the last 60 years, it has been well established that cancer and nutrition are intrinsically connected”, said Yuri Nikolsky, CEO of GeneGo and the grant’s PI.
”However, this knowledge is scattered in thousands of sources, which are difficult to annotate and categorize. We will assemble the first specialized database on the topic and develop automated tools for data analysis. The new platform will be primarily targeting healthcare professionals and nutritionists.”
Researchers have developed an artificial enzymatic pathway for synthesizing isoprenoids, or terpenes, in E. coli. This shorter, more efficient, cost-effective and customizable pathway transforms E. coli into a factory that can produce terpenes for use in everything from cancer drugs to biofuels.READ MORE
2nd International Conference on Pharmaceutical Research & Innovations in Pharma Industry
May 30 - May 31, 2019
16th International Conference on Structural Biology
Mar 11 - Mar 12, 2019